Women's beliefs about methods and contraceptive discontinuation: Results from a prospective study from Nairobi and Homa Bay counties in Kenya.

Homa Bay Nairobi attributes beliefs discontinuation method related

Journal

Frontiers in global women's health
ISSN: 2673-5059
Titre abrégé: Front Glob Womens Health
Pays: Switzerland
ID NLM: 101776281

Informations de publication

Date de publication:
2023
Historique:
received: 01 09 2022
accepted: 23 02 2023
medline: 31 3 2023
entrez: 30 3 2023
pubmed: 31 3 2023
Statut: epublish

Résumé

Rates of contraceptive discontinuation are high in many low and middle countries contributing to unmet need for contraception and other adverse reproductive health outcomes. Few studies have investigated how women's beliefs about methods and strength of fertility preferences affect discontinuation rates. This study examines this question using primary data collected in Nairobi and Homa Bay counties in Kenya. We used data from two rounds of a longitudinal study of married women ages 15-39 years (2,812 and 2,424 women from Nairobi and Homa Bay respectively at round 1). Information on fertility preferences, past and current contraceptive behavior, and method-related beliefs about six modern contraceptive methods were collected, along with a monthly calendar of contraceptive use between the two interviews. The analysis focused on discontinuation of the two most commonly used methods in both sites, injectables and implants. We carry out competing risk survival analysis to identify which method related beliefs predict discontinuation among women using at the first round. The percentages of episodes discontinued in the 12 months between the two rounds was 36%, with a higher rate of discontinuation in Homa Bay (43%) than in the Nairobi slums (32%) and higher for injectables than implants. Method related concerns and side effects were the major self-reported reasons for discontinuation in both sites. The competing risk survival analysis showed that the probability of method related discontinuation of implants and injectables was significantly lower among respondents who believed that the methods do not cause serious health problems (SHR = 0.78, 95% CI: 0.62-0.98), do not interfere with regular menses (SHR = 0.76, 95% CI: 0.61-0.95) and do not cause unpleasant side effects (SHR = 0.72, 95% CI 0.56-0.89). By contrast, there were no net effects of three method related beliefs that are commonly cited as obstacles to contraceptive use in African societies: safety for long-term use, ability to have children after stopping the method, and the approval of the husband. This study is unique in its examination of the effect of method-specific beliefs on subsequent discontinuation for a method-related reason, using a longitudinal design. The single most important result is that concerns about serious health problems, which are largely unjustified and only moderately associated with beliefs about side effects, are a significant influence on discontinuation. The negative results for other beliefs show that the determinants of discontinuation differ from the determinants of method adoption and method choice.

Sections du résumé

Background UNASSIGNED
Rates of contraceptive discontinuation are high in many low and middle countries contributing to unmet need for contraception and other adverse reproductive health outcomes. Few studies have investigated how women's beliefs about methods and strength of fertility preferences affect discontinuation rates. This study examines this question using primary data collected in Nairobi and Homa Bay counties in Kenya.
Methods UNASSIGNED
We used data from two rounds of a longitudinal study of married women ages 15-39 years (2,812 and 2,424 women from Nairobi and Homa Bay respectively at round 1). Information on fertility preferences, past and current contraceptive behavior, and method-related beliefs about six modern contraceptive methods were collected, along with a monthly calendar of contraceptive use between the two interviews. The analysis focused on discontinuation of the two most commonly used methods in both sites, injectables and implants. We carry out competing risk survival analysis to identify which method related beliefs predict discontinuation among women using at the first round.
Results UNASSIGNED
The percentages of episodes discontinued in the 12 months between the two rounds was 36%, with a higher rate of discontinuation in Homa Bay (43%) than in the Nairobi slums (32%) and higher for injectables than implants. Method related concerns and side effects were the major self-reported reasons for discontinuation in both sites. The competing risk survival analysis showed that the probability of method related discontinuation of implants and injectables was significantly lower among respondents who believed that the methods do not cause serious health problems (SHR = 0.78, 95% CI: 0.62-0.98), do not interfere with regular menses (SHR = 0.76, 95% CI: 0.61-0.95) and do not cause unpleasant side effects (SHR = 0.72, 95% CI 0.56-0.89). By contrast, there were no net effects of three method related beliefs that are commonly cited as obstacles to contraceptive use in African societies: safety for long-term use, ability to have children after stopping the method, and the approval of the husband.
Conclusion UNASSIGNED
This study is unique in its examination of the effect of method-specific beliefs on subsequent discontinuation for a method-related reason, using a longitudinal design. The single most important result is that concerns about serious health problems, which are largely unjustified and only moderately associated with beliefs about side effects, are a significant influence on discontinuation. The negative results for other beliefs show that the determinants of discontinuation differ from the determinants of method adoption and method choice.

Identifiants

pubmed: 36994242
doi: 10.3389/fgwh.2023.1034634
pmc: PMC10040827
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1034634

Informations de copyright

© 2023 Wado, Mutua, Odwe, Obare, Machiyama, Casterline and Cleland.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Open Access J Contracept. 2017 Jul 10;8:45-52
pubmed: 29386952
Soc Sci Med. 2010 Nov;71(9):1584-92
pubmed: 20869146
Reprod Health. 2017 Feb 9;14(1):23
pubmed: 28183308
Int Fam Plan Perspect. 2005 Mar;31(1):15-23
pubmed: 15888405
J Biosoc Sci. 2019 Jul;51(4):491-504
pubmed: 30309402
Int Perspect Sex Reprod Health. 2013 Sep;39(3):133-41
pubmed: 24135045
BMC Public Health. 2015 Feb 10;15:118
pubmed: 25884675
Gates Open Res. 2019 May 2;3:1453
pubmed: 32140663
Reprod Health. 2021 Feb 9;18(1):33
pubmed: 33563304
J Biosoc Sci. 1999 Jul;31(3):343-60
pubmed: 10453247
Stud Fam Plann. 2020 Jun;51(2):119-137
pubmed: 32515508
Rev Panam Salud Publica. 2008 Jun;23(6):410-7
pubmed: 18644209
PLoS One. 2021 Jan 12;16(1):e0238662
pubmed: 33434205
Reprod Health. 2018 May 8;15(1):75
pubmed: 29739429
Stud Fam Plann. 2002 Jun;33(2):127-40
pubmed: 12132634
Circulation. 2016 Feb 9;133(6):601-9
pubmed: 26858290
Stud Fam Plann. 2007 Mar;38(1):23-34
pubmed: 17385380
Lifetime Data Anal. 2013 Jan;19(1):33-58
pubmed: 23010807
Sex Reprod Health Matters. 2020 Dec;28(1):1723321
pubmed: 32178594
PLoS One. 2020 Nov 5;15(11):e0241605
pubmed: 33151972
Stud Fam Plann. 2017 Sep;48(3):269-278
pubmed: 28398595
Stud Fam Plann. 2015 Dec;46(4):369-86
pubmed: 26643488
PLoS One. 2021 Jun 18;16(6):e0252977
pubmed: 34143804
Matern Child Health J. 2011 May;15(4):497-506
pubmed: 20428934
Contracept X. 2020 Jun 20;2:100030
pubmed: 32642642
Contraception. 1986 Dec;34(6):573-82
pubmed: 3549141
Stud Fam Plann. 2018 Sep;49(3):279-292
pubmed: 30125375
Cult Health Sex. 2021 Dec;23(12):1748-1762
pubmed: 32795154
Int Perspect Sex Reprod Health. 2011 Jun;37(2):58-66
pubmed: 21757420
Stud Fam Plann. 2011 Mar;42(1):11-20
pubmed: 21500697

Auteurs

Yohannes Dibaba Wado (YD)

Health and Wellbeing Program, African Population and Health Research Center, APHRC Campus, Nairobi, Kenya.

Martin K Mutua (MK)

Health and Wellbeing Program, African Population and Health Research Center, APHRC Campus, Nairobi, Kenya.

George Odwe (G)

Population Council - Kenya, Nairobi, Kenya.

Francis Obare (F)

Population Council - Kenya, Nairobi, Kenya.

Kazuyo Machiyama (K)

Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.

John B Casterline (JB)

Department of Sociology, Ohio State University, Columbus, OH, United States.

John Cleland (J)

Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Classifications MeSH